2-Methylbutyrylcaitine, a metabolite of fatty acids, predominantly exists in human and animal blood and urine, resulting from the pyruvate carboxylation pathway. It is notably elevated in the plasma of individuals with steatohepatitis (NASH), serving as a biomarker for diagnosing metabolic diseases (1).